Broker Recommendations
JPMorgan cuts European banks ‘overweight’ against US banks to ‘neutral’
JPMorgan Cazenove said on Tuesday that it was remaining positive on European banks, moving from ‘overweight’ Europe versus US banks to ‘neutral’, considering the discount of just 16% for Europe to US banks today.
JPMorgan upgrades mining & metals sector to ‘overweight’
JPMorgan upgraded the global mining and metals sector to ‘overweight’ from ‘underweight’ on Monday, as it said that Rio Tinto, Antofagasta, Fresnillo & SSAB are its European key ‘overweights’.
RBC Capital upgrades Capita to ‘outperform’
RBC Capital Markets upgraded Capita on Monday to ‘outperform’ form ‘sector perform’ and lifted the price target to 2,000p from 1,700p as it said the risk/reward was now in favour.
Shore Capital upgrades ASOS on H1 profit beat
Shore Capital has upgraded ASOS from 'hold' to 'buy' after first-half earnings came in ahead of forecasts on Friday.
RBC Capital upgrades Crest Nicholson to ‘outperform’, lifts price target
RBC Capital Markets upgraded Crest Nicholson on Friday to ‘outperform’ from ‘sector perform’ and hiked the price target to 230p from 180p after the housebuilder's capital markets day on Thursday.
BofA stays at 'buy' on Prudential
Analysts at Bank of America reiterated their 'buy' recommendation for shares of Prudential on the back of the insurance and wealth management outfit's latest results.
RBC Capital reiterates ‘outperform’ on Schroders, hikes price target
RBC Capital Markets reiterated its ‘outperform’ rating on Schroders on Thursday and hiked its price target to 475p from 395p as it lifted its adjusted operating earnings estimates by 1%/6%/9% over FY25/26/27, updating the FY24 results and strategy evolution.
BNP Exane downgrades Compass Group, shares slide
Compass Group slumped on Wednesday after BNP Paribas Exane downgraded shares of the catering firm to ‘underperform’ from ‘outperform’.
Citi upgrades Bridgepoint to 'buy'
Bridgepoint gained on Wednesday after an upgrade to ‘buy’ from ‘neutral’ at Citi, which said the risk-reward looks attractive following recent underperformance.
Berenberg slashes QinetiQ price target, reiterates ‘buy’ rating
Berenberg slashed its price target on QinetiQ on Wednesday to 500p from 610p to reflect lowered estimates, but reiterated its ‘buy’ rating.
QinetiQ needs to 'rebuild trust' after profit warning, says Shore Capital
Shore Capital on Tuesday cut its recommendation for QinetiQ from 'buy' to 'hold' following a profit warning from the UK defence contractor on Monday.
JPMorgan moves to ‘overweight’ on Rio Tinto following period of restriction
JPMorgan Cazenove moved to an ‘overweight’ rating on Rio Tinto on Tuesday and 5,920p price target following a period of restriction during which the stock was not rated.
RBC Capital upgrades Anglo American to ‘sector perform’
RBC Capital Markets upgraded Anglo American on Tuesday to ‘sector perform’ from ‘underperform’ and lifted the price target to 2,310p from 2,200p.
Berenberg says ‘buy the dip’ on ‘top pick’ Currys
Berenberg recommended on Monday that investors ‘buy the dip’ in Currys, as it hailed the electricals retailer as a "top pick" for 2025.
RBC Capital upgrades CVS Group to ‘outperform’, shares surge
CVS Group surged on Monday after RBC Capital Markets upgraded the shares to ‘outperform’ from ‘sector perform’ on forthcoming clarity from the Competition and Markets Authority and Australian margins, and hiked the price target to 1,500p from 940p.
UBS upgrades Ashmore to ‘buy’, shares surge
Ashmore surged on Friday after UBS upgraded shares of the emerging markets investment manager to ‘buy’ from ‘neutral’ and lifted the price target 180p from 175p, as it said flow momentum, investor rotations and an attractive valuation lead to a favourable risk-reward.
Melrose Industries ‘presents compelling investment opportunity’, says Citi
Citi reiterated its ‘buy’ rating on Melrose Industries on Friday as it said it "presents a compelling investment opportunity", sending shares in the aerospace manufacturing firm higher.
Berenberg lowers target price on Spire Healthcare following FY24 results
Analysts at Berenberg lowered their target price on Spire Healthcare from 300. 0p to 255. 0p on Friday after the firm reported weaker-than-expected, missing consensus expectations across revenues, as well as adjusted underlying earnings and adjusted EPS.
JPMorgan puts Burberry, Kering on ‘negative catalyst watch’
JPMorgan Cazenove placed Burberry on ‘negative catalyst watch’ on Friday into FY25 results on 19 May.
Berenberg downgrades Synthomer to 'hold', lowers target price
Analysts at Berenberg downgraded speciality chemicals firm Synthomer from 'buy' to 'hold' on Thursday and cut its target price on the stock from 230. 0p to 150. 0p, stating the "margin of safety" was now "too thin".